# Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.

> **NCT03539627** · — · COMPLETED · sponsor: **Research Institute for Complex Problems of Cardiovascular Diseases, Russia** · enrollment: 184 (actual)

## Conditions studied

- Arterial Hypertension
- Diabetes Mellitus
- Stable Chronic Angina

## Interventions

- **DRUG:** Azilsartan Medoxomil 40 MG Oral Tablet [Edarbi]

## Key facts

- **NCT ID:** NCT03539627
- **Lead sponsor:** Research Institute for Complex Problems of Cardiovascular Diseases, Russia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-07
- **Primary completion:** 2022-04-29
- **Final completion:** 2022-04-29
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03539627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03539627, "Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03539627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*